NF-κB signaling pathway as target for antiplatelet activity

被引:32
作者
Fuentes, Eduardo [1 ,2 ]
Rojas, Armando [3 ]
Palomo, Ivan [1 ,2 ]
机构
[1] Univ Talca, Interdisciplinary Excellence Res Program Hlth Agi, Dept Clin Biochem & Immunohematol, Lab Hematol & Immunol,Fac Hlth Sci, Talca, Chile
[2] CONICYT Reg, CEAP, R0912001, Talca, Chile
[3] Catholic Univ Maule, Biomed Res Labs, Fac Med, Talca, Chile
关键词
Platelet activation; NF-kappa B; Thrombin; sCD40L/CD40L; Toll-like receptors; RAGE; PPARs; GLYCOSYLATION END-PRODUCTS; ACTIVATED RECEPTOR-GAMMA; PROTEIN-KINASE-A; PLATELET-AGGREGATION; THROMBUS FORMATION; PPAR-GAMMA; GENE-EXPRESSION; CD40; LIGAND; DIFFERENTIAL REGULATION; ADHESION MOLECULE-1;
D O I
10.1016/j.blre.2016.03.002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In different nucleated cells, NF-kappa B has long been considered a prototypical proinflammatory signaling pathway with the expression of proinflammatory genes. Although platelets lack a nucleus, a number of functional transcription factors are involved in activated platelets, such as NF-kappa B. In platelet activation NF-kappa B regulation events include IKK beta phosphorylation, I kappa B alpha degradation, and p65 phosphorylation. Multiple pathways contribute to platelet activation and NF-kappa B is a common pathway in this activation. Therefore, in platelet activation the modulation of NF-kappa B pathway could be a potential new target in the treatment of inflammation-related vascular disease therapy (antiplatelet and antithrombotic activities). (C) 2016 Elsevier Ltd. All rights reserved.
引用
收藏
页码:309 / 315
页数:7
相关论文
共 143 条
[1]   Role of phosphodiesterase 3 in NO/cGMP-mediated antiinflammatory effects in vascular smooth muscle cells [J].
Aizawa, T ;
Wei, H ;
Miano, JM ;
Abe, J ;
Berk, BC ;
Yan, C .
CIRCULATION RESEARCH, 2003, 93 (05) :406-413
[2]   Human bone marrow megakaryocytes and platelets express PPARγ, and PPARγ agonists blunt platelet release of CD40 ligand and thromboxanes [J].
Akbiyik, F ;
Ray, DM ;
Gettings, KF ;
Blumberg, N ;
Francis, CW ;
Phipps, RP .
BLOOD, 2004, 104 (05) :1361-1368
[3]   Role of nuclear receptor signaling in platelets: antithrombotic effects of PPARβ [J].
Ali, Ferhana Y. ;
Davidson, Simon J. ;
Moraes, Leonardo A. ;
Traves, Suzanne L. ;
Paul-Clark, Mark ;
Bishop-Bailey, David ;
Warner, Timothy D. ;
Mitchell, Jane A. .
FASEB JOURNAL, 2006, 20 (02) :326-328
[4]   Effects of bortezomib on platelet aggregation and ATP release in human platelets, in vitro [J].
Avcu, Ferit ;
Ural, A. Ugur ;
Cetin, Turker ;
Nevruz, Oral .
THROMBOSIS RESEARCH, 2008, 121 (04) :567-571
[5]   Activation of the small GTPases, rac and cdc42, after ligation of the platelet PAR-1 receptor [J].
Azim, AC ;
Barkalow, K ;
Chou, J ;
Hartwig, JH .
BLOOD, 2000, 95 (03) :959-964
[6]   THE INDUCIBLE TRANSCRIPTION ACTIVATOR NF-KAPPA-B - REGULATION BY DISTINCT PROTEIN SUBUNITS [J].
BAEUERLE, PA .
BIOCHIMICA ET BIOPHYSICA ACTA, 1991, 1072 (01) :63-80
[7]   A 65-KD SUBUNIT OF ACTIVE NF-KAPPA-B IS REQUIRED FOR INHIBITION OF NF-KAPPA-B BY I-KAPPA-B [J].
BAEUERLE, PA ;
BALTIMORE, D .
GENES & DEVELOPMENT, 1989, 3 (11) :1689-1698
[8]   I-KAPPA-B - A SPECIFIC INHIBITOR OF THE NF-KAPPA-B TRANSCRIPTION FACTOR [J].
BAEUERLE, PA ;
BALTIMORE, D .
SCIENCE, 1988, 242 (4878) :540-546
[9]   NF-κB, Inflammation, and Metabolic Disease [J].
Baker, Rebecca G. ;
Hayden, Matthew S. ;
Ghosh, Sankar .
CELL METABOLISM, 2011, 13 (01) :11-22
[10]   Regulatory effects of TLR2 on megakaryocytic cell function [J].
Beaulieu, Lea M. ;
Lin, Elaine ;
Morin, Kristine M. ;
Tanriverdi, Kahraman ;
Freedman, Jane E. .
BLOOD, 2011, 117 (22) :5963-5974